US FDA executive to head AAMI's device standards programme
This article was originally published in SRA
Carol Herman, a senior executive of the US Food and Drug Administration, is to join the Association for the Advancement of Medical Instrumentation (AAMI) as the organisation's new senior vice president for standards policy and programmes1.
You may also be interested in...
A new work sharing pilot has been launched to evaluate jointly generic drugs intended for launch in Singapore and Malaysia.
The World Health Organization has proposed changes to its 2016 guideline on data integrity requirements to provide streamlined information to sponsors and to take account of experience gained to date.
EU regulators say that sponsors must complete their nitrosamine-related risk evaluations for all EU medicines containing chemically-synthesised active substances within the six-month timeframe.